196 related articles for article (PubMed ID: 35341461)
21. Notch1 signaling regulates the epithelial-mesenchymal transition and invasion of breast cancer in a Slug-dependent manner.
Shao S; Zhao X; Zhang X; Luo M; Zuo X; Huang S; Wang Y; Gu S; Zhao X
Mol Cancer; 2015 Feb; 14(1):28. PubMed ID: 25645291
[TBL] [Abstract][Full Text] [Related]
22. CRTAC1 (Cartilage acidic protein 1) inhibits cell proliferation, migration, invasion and epithelial-mesenchymal transition (EMT) process in bladder cancer by downregulating Yin Yang 1 (YY1) to inactivate the TGF-β pathway.
Yang J; Fan L; Liao X; Cui G; Hu H
Bioengineered; 2021 Dec; 12(2):9377-9389. PubMed ID: 34818994
[TBL] [Abstract][Full Text] [Related]
23. MYB proto-oncogene like 2 promotes hepatocellular carcinoma growth and glycolysis via binding to the
Liu M; Du Q; Mao G; Dai N; Zhang F
Bioengineered; 2022 Mar; 13(3):5344-5356. PubMed ID: 35176941
[TBL] [Abstract][Full Text] [Related]
24. Knockdown of FAM64A suppresses proliferation and migration of breast cancer cells.
Yao Z; Zheng X; Lu S; He Z; Miao Y; Huang H; Chu X; Cai C; Zou F
Breast Cancer; 2019 Nov; 26(6):835-845. PubMed ID: 31264076
[TBL] [Abstract][Full Text] [Related]
25. Overexpression of microRNA-190 inhibits migration, invasion, epithelial-mesenchymal transition, and angiogenesis through suppression of protein kinase B-extracellular signal-regulated kinase signaling pathway via binding to stanniocalicin 2 in breast cancer.
Sun G; Liu M; Han H
J Cell Physiol; 2019 Aug; 234(10):17824-17838. PubMed ID: 30993707
[TBL] [Abstract][Full Text] [Related]
26. TRIM66 promotes malignant progression of hepatocellular carcinoma by inhibiting E-cadherin expression through the EMT pathway.
Zhang HG; Pan YW; Feng J; Zeng CT; Zhao XQ; Liang B; Zhang WW
Eur Rev Med Pharmacol Sci; 2019 Mar; 23(5):2003-2012. PubMed ID: 30915743
[TBL] [Abstract][Full Text] [Related]
27. Oct4 promoted proliferation, migration, invasion, and epithelial-mesenchymal transition (EMT) in colon cancer cells by activating the SCF/c-Kit signaling pathway.
Bu X; Liu Y; Wang L; Yan Z; Xin G; Su W
Cell Cycle; 2023 Feb; 22(3):291-302. PubMed ID: 36258646
[TBL] [Abstract][Full Text] [Related]
28. [High expression of MYBL2 promotes progression and predicts a poor survival outcome of prostate cancer].
Yang M; Zhu X; Shen Y; He Q; Qin Y; Shao Y; Yuan L; Ye H
Nan Fang Yi Ke Da Xue Xue Bao; 2022 Aug; 42(8):1109-1118. PubMed ID: 36073208
[TBL] [Abstract][Full Text] [Related]
29. Long non-coding RNA BANCR indicates poor prognosis for breast cancer and promotes cell proliferation and invasion.
Lou KX; Li ZH; Wang P; Liu Z; Chen Y; Wang XL; Cui HX
Eur Rev Med Pharmacol Sci; 2018 Mar; 22(5):1358-1365. PubMed ID: 29565494
[TBL] [Abstract][Full Text] [Related]
30. Long non-coding RNA linc00673 regulated non-small cell lung cancer proliferation, migration, invasion and epithelial mesenchymal transition by sponging miR-150-5p.
Lu W; Zhang H; Niu Y; Wu Y; Sun W; Li H; Kong J; Ding K; Shen HM; Wu H; Xia D; Wu Y
Mol Cancer; 2017 Jul; 16(1):118. PubMed ID: 28697764
[TBL] [Abstract][Full Text] [Related]
31. miR-381 inhibited breast cancer cells proliferation, epithelial-to-mesenchymal transition and metastasis by targeting CXCR4.
Xue Y; Xu W; Zhao W; Wang W; Zhang D; Wu P
Biomed Pharmacother; 2017 Feb; 86():426-433. PubMed ID: 28012397
[TBL] [Abstract][Full Text] [Related]
32. Circ_0006332 promotes growth and progression of bladder cancer by modulating MYBL2 expression via miR-143.
Li M; Liu Y; Liu J; Li W; Li N; Xue D; Zhang X; Wang P
Aging (Albany NY); 2019 Nov; 11(22):10626-10643. PubMed ID: 31756170
[TBL] [Abstract][Full Text] [Related]
33. MYB mediates downregulation of the colorectal cancer metastasis suppressor heterogeneous nuclear ribonucleoprotein L-like during epithelial-mesenchymal transition.
Sakuma K; Sasaki E; Hosoda W; Komori K; Shimizu Y; Yatabe Y; Aoki M
Cancer Sci; 2021 Sep; 112(9):3846-3855. PubMed ID: 34286904
[TBL] [Abstract][Full Text] [Related]
34. URG11 promotes proliferation and induced apoptosis of LNCaP cells.
Sun C; Zhang G; Cheng S; Qian H; Li D; Liu M
Int J Mol Med; 2019 May; 43(5):2075-2085. PubMed ID: 30864678
[TBL] [Abstract][Full Text] [Related]
35. lncRNA MIAT Regulates Cell Growth, Migration, and Invasion Through Sponging miR-150-5p in Ovarian Cancer.
Zhou S; Xu A; Song T; Gao F; Sun H; Kong X
Cancer Biother Radiopharm; 2020 Nov; 35(9):650-660. PubMed ID: 32186927
[No Abstract] [Full Text] [Related]
36. miR‑205 suppresses cell migration, invasion and EMT of colon cancer by targeting mouse double minute 4.
Fan Y; Wang K
Mol Med Rep; 2020 Aug; 22(2):633-642. PubMed ID: 32467998
[TBL] [Abstract][Full Text] [Related]
37. MicroRNA-520c-3p negatively regulates EMT by targeting IL-8 to suppress the invasion and migration of breast cancer.
Tang CP; Zhou HJ; Qin J; Luo Y; Zhang T
Oncol Rep; 2017 Nov; 38(5):3144-3152. PubMed ID: 29048659
[TBL] [Abstract][Full Text] [Related]
38. MicroRNA-543 inhibits the proliferation, migration, invasion, and epithelial-mesenchymal transition of triple-negative breast cancer cells via down-regulation of ACTL6A gene.
Wang YL; Liang RH; Wang CY; Zhang RP; Wu SY; Han X; Zhang GL
Clin Transl Oncol; 2022 Jan; 24(1):84-92. PubMed ID: 34181232
[TBL] [Abstract][Full Text] [Related]
39. Down-regulation of lncRNA Linc00152 suppressed cell viability, invasion, migration, and epithelial to mesenchymal transition, and reversed chemo-resistance in breast cancer cells.
Hu XL; Wang J; He W; Zhao P; Wu WQ
Eur Rev Med Pharmacol Sci; 2018 May; 22(10):3074-3084. PubMed ID: 29863253
[TBL] [Abstract][Full Text] [Related]
40. miR-516a-3p inhibits breast cancer cell growth and EMT by blocking the Pygo2/Wnt signalling pathway.
Chi Y; Wang F; Zhang T; Xu H; Zhang Y; Shan Z; Wu S; Fan Q; Sun Y
J Cell Mol Med; 2019 Sep; 23(9):6295-6307. PubMed ID: 31273950
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
